A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Conditions: Primary Open Angle Glaucoma; Ocular Hypertension Interventions: Drug: TFC-003; Drug: COSOPT ophthalmic solution Sponsors: Kukje Pharma Not yet recruiting

https://clinicaltrials.gov/study/NCT06177678

Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials